MARKETS

BSE Prices delayed by 5 minutes... Prices as on May 22, 2019 - 4:01PM   ABB India 1452.2 [ 1.84% ]ACC 1616.1 [ 0.24% ]Ambuja Cements Ltd. 220.05 [ -0.23% ]Asian Paints Ltd. 1366.75 [ 0.60% ]Axis Bank Ltd. 779.3 [ 0.80% ]Bajaj Auto Ltd. 3049.05 [ 2.29% ]Bank of Baroda 126.2 [ 0.68% ]Bharti Airtel 336.85 [ 1.83% ]Bharat Heavy Ele 65.25 [ 3.00% ]Bharat Petroleum 384.3 [ 2.56% ]Britannia Ind. 2851.25 [ 0.18% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 554.05 [ -0.84% ]Coal India 240.3 [ 1.26% ]Colgate Palm. 1154 [ -0.42% ]Dabur India 384.6 [ 0.47% ]DLF Ltd. 173.85 [ 1.55% ]Dr. Reddy's Labs 2658.95 [ -0.14% ]GAIL (India) Ltd. 337.9 [ -0.28% ]Grasim Inds. 857.2 [ -1.04% ]HCL Technologies 1059.2 [ 0.21% ]HDFC 2140.6 [ 1.25% ]HDFC Bank 2405.1 [ 0.05% ]Hero MotoCorp 2695 [ 1.44% ]Hindustan Unilever L 1766.15 [ -0.97% ]Hindalco Indus. 198.55 [ 1.30% ]ICICI Bank 406.1 [ 1.44% ]IDFC L 36.15 [ -0.96% ]Indian Hotels Co 148.5 [ -0.57% ]IndusInd Bank 1517.55 [ 4.84% ]Infosys 709.2 [ 0.00% ]ITC Ltd. 299.55 [ -1.88% ]Jindal St & Pwr 152.05 [ -6.80% ]Kotak Mahindra Bank 1502 [ 1.00% ]L&T 1460.55 [ 0.85% ]Lupin Ltd. 756.35 [ 1.18% ]Mahi. & Mahi 640 [ 0.19% ]Maruti Suzuki India 6904.1 [ 0.68% ]MTNL 8.61 [ 0.58% ]Nestle India 10689.9 [ 0.89% ]NIIT Ltd. 100.2 [ -1.13% ]NMDC Ltd. 94.8 [ 1.72% ]NTPC 129.6 [ 0.90% ]ONGC 176.75 [ 1.41% ]Punj. NationlBak 84.65 [ -1.74% ]Power Grid Corpo 182.1 [ -1.03% ]Reliance Inds. 1340.7 [ 0.07% ]SBI 340.85 [ 0.98% ]Vedanta 166.45 [ 0.60% ]Shipping Corpn. 31.05 [ 0.16% ]Sun Pharma. 420.65 [ 2.92% ]Tata Chemicals 620.7 [ 0.77% ]Tata Global Beverage 233.5 [ 0.58% ]Tata Motors Ltd. 179.45 [ 1.61% ]Tata Steel 473.7 [ 0.04% ]Tata Power Co. 64.85 [ 0.70% ]Tata Consultancy 2082.75 [ -1.25% ]Tech Mahindra Ltd. 750 [ -3.03% ]UltraTech Cement 4646.95 [ -0.04% ]United Spirits 541.75 [ -1.69% ]Wipro Ltd 283.2 [ -1.27% ]Zee Entertainment En 342.8 [ -1.52% ]

News Details

You can view in detail.
Zydus Cadila gets USFDA nod to market generic Sitagliptin and Metformin Hydrochloride 14/03/2019 16:48

Drug firm Zydus Cadila on Thursday said it has received tentative nod from the US health regulator to market generic Sitagliptin and Metformin Hydrochloride extended-release tablets used for controlling blood sugar levels.

The company has received the tentative approval from the United States Food and Drug Administration (USFDA) to market Sitagliptin and Metformin Hydrochloride extended-release tablets in the strength of 50 mg/500 mg, 50 mg/1,000 mg and 100 mg/1,000 mg

The product is the generic version of Janumet XR tablets, it added.

The tablets will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad, Zydus Cadila said.

The product contains two oral anti-diabetic medications used in the management of type 2 diabetes, it added.

The group now has 255 approvals and has so far filed over 350 abbreviated new drug applications (ANDAs) since the commencement of its filing process, Zydus Cadila said.

LOAD MORE